TDRD Flashcards
So What makes a drug an Ideal Agent?
Hypnosis and amnesia
Rapid onset and rapid metabolism to inactive metabolites
Minimal CV or respiratory depression
No histamine release, non-toxic, nonirritating
No untoward neurologic issues (seizures, myoclonus or neurotoxicity)
Good analgesic, antiemetic and cardio protective
5 rights
Right drug, patient, dose, route, time
Propofol (Diprivan)
Stimulation of GABA, highly lipid soluble
Uses: TIVA, induction, antiemetic qualities, outpatient surgery, endoscopy, MAC
Contraindicated in allergies to eggs, egg products, soybeans or soy products (?)
Pain on injection (Lidocaine: to mix or not to mix)
Can support bacteria
Good up to 12 hours in opened vial
Good for 6 hours after being drawn into a syringe
CV: decrease HR and BP, decreased SVR
Dose dependent respiratory depression
Minimal residual CNS effects
Decrease in CBF and ICP
Protein binding: 97% to 99%
Dosing:
1-2.5 mg/kg IV induction (2 mg); 25-200 mcq/kg/min sedation/maintenance
Pharmacodynamics
Onset: 30 sec
Duration: dose and rate dependent
Elderly:
More sensitive, prolonged effects possibly due to decreased CO and clearance
Children:
Large volume of distribution and quicker clearance (may need larger dose)
Obese:
Base dosing on lean body weight
Chronic Alcoholism? CV Disease?
Lidocaine
Dose: 0.5-1.5 mg/kg (adjusted dependent on the patient)
Older adults: 0.5-1 mg/kg
- Hemodynamically unstable: keep less then .5mg/kg
- Keep it on the lower side if they are less than 60 kg (?)
Administered to:
- Suppress the coughing reflex during laryngoscopy and intubation
- Reduce airway responsiveness to noxious stimuli
- Reduces pain caused by IV injection agents
It might increase the hypotensive effects of sedative-hypnotic agents
Careful in cardiac patients
Ketamine (Ketalar)
Noncompetitive NMDA receptor antagonist that blocks glutamate
Stimulates SNS: inhibits the re-uptake of Norepinephrine, dissociative anesthetic
Indications: induction, sedation, CV collapse, sedation for mentally challenged, “bad” epidural/spinal
Effects:
Intense analgesia (review the opioid receptors)
CV: increase in BP, HR, CO, PAP, CVP, CI
Respiratory: minimal depression, maintains upper airway reflexes, increased oral secretions (Glyco), bronchodilator
Emergence delirium: low lights, quiet room, VERSED
Increases in ICP?
Phencyclidine derivative, hallucinogenic, use VERSED
Norketamine is an active metabolite, 1/3 to 1/5th as potent as Ketamine
Dosing
Induction: 1-2 mg/kg IV, 4-5 mg/kg IM, titrated for effect
In Low doses it can be opioid sparing
Pharmacodynamics
Onset: IV in 30 sec; IM in 2-4 min
Duration: 10-15 min (IV), 15-25 min (IM)
Can use Ketamine in Bronchospastic Patients
**Know it*
Thiopental (Pentathol)
Introduced in 1934
No longer available in the United States or elsewhere
Short acting barbiturate, activates GABA
Uses: Sedative, hypnotic, anticonvulsant, treatment of ICP (neuro cases), induction of anesthesia
Effects:
Hypotension
Decrease in CBP and ICP
May increase N/V
Some histamine release
500mg vial
Contraindicated in:
Acute Intermittent Porphyria or Variegate Porphyria
Status Asthmaticus
Protein Binding: 72%-86%
Avoid extravasation necrosis
Dosing:
Induction: 3-5 mg/kg IV in adults
Pharmacodynamics
Onset: 30-60 sec
Duration: 5-30 min
Hepatic metabolism
Etomidate (Amidate)
Ultrashort-acting nonbarbiturate hypnotic, depresses RAS
Uses: induction, procedural sedation
Effects:
Minimal CV effects, decrease in CMR, CBF, ICP
Respiratory depression
Potential for increased N/V and pain on injection (per Dr. Havenstein and Crosse??????). WHY can it burn? glycerol
Myoclonic movements can be decreased with opioids
Temporary Adrenocortical suppression limits long-term use
Protein Binding: 76%
Dosing:
Induction: 0.2-0.3 mg/kg
Pharmacodynamics
Onset: 30-60 seconds
Hepatic enzyme and plasma esterase hydrolysis
Dexmedetomidine (Precedex)
Highly selective, potent central acting Alpha2 adrenergic agonist, results in inhibition of norepinephrine release
Uses: procedural sedation, analgesia, awake fiberoptic intubation, postop sedation, pediatrics
Effects:
Bradycardia, sinus arrest and hypotension (tx with atropine, ephedrine and volume)
Dose dependent analgesia, anxiolysis and sedation with minimal respiratory depression
Protein Binding: 94%
Dosing RANGES:
Procedural sedation: 0.5 -1 mcg/kg over 10 min: infusion .3-.7 mcg/kg/hour
Awake Fiberoptic intubation: 1 mcg/kg over 10 min: infusion 0.7 mcg/kg/hour until intubated
Pharmacodynamics
Onset: 5-10 min; peaks in 15-30 min
Duration: 60-120 min (dose dependent)
Hepatic metabolism
Urinary excretion
Methohexital (Brevital)
Rapid Ultrashort-acting barbiturate, enhances effects of GABA
Uses: ECT(gold standard), ENDO, very short procedures
Effects: deep sedation, skeletal muscle hyperactivity, pain on injection
Must be reconstituted into a 1% (10mg/cc) solution for intermittent IV use
Shortest acting barbiturate and does NOT have anticonvulsant activity (lowers the seizure threshold)
Great for Electroconvulsive Therapy
Pharmacodynamics
Dose: 1-1.5 mg/kg
Onset: < 1 min
Duration: 5-7 minutes
Hepatic metabolism
Urinary Excretion
RAPID redistribution
What are 3 ways to cause muscle relaxation?
Regional, neuromuscular blocker, inhalational anesthetic
Neuromuscular blockers listed
Depolarizing – succinylcholine (Anectine, SCH)
Nondepolarizing:
Rocuronium (Zemuron)
Vecuronium (Norcuron)
Pancuronium (Pavulon)
Benzylisoquinolines:
Mivacurium (Mivacron)
Atracurium (tracrium)
Cisatracurium (Nimbex)
Depolarizing Relaxant
Succinylcholine (suxamethonium, Quelicin, SCH or Anectine) (200mg - 20mg/ml)
Binds to 2 alpha subunits of nicotinic cholinergic receptors, allows sodium and calcium influx, potassium efflux, resulting depolarization of muscle
Remains depolarized until SCH diffuses away from receptor
Mimics action of Acetylcholine (AcH)
Uses: rapid muscle relaxation, routine intubation, very short cases, OB, RSI, Laryngospasm
What you should know about SUX!
Can cause Hyperkalemia
Triggering Agent for Malignant Hyperthermia
Minimal Histamine release
Decrease HR due to muscarinic stimulation
SCH apnea/Psuedocholinesterase Abnormality
Phase I normally
Phase II block from large or repeated doses
Fasciculation’s can cause muscle pain Postop
In children, increased risk of increased K and cardiac arrest from undiagnosed myopathies
Metabolism:
Butyrylcholinesterase (synthesized by the liver and found in the plasma) also called plasma cholinesterase
SCH diffuses away from the NMJ, hydrolyzed in the plasma by plasma cholinesterase
Decreased levels of pseudocholinesterase can prolong the block (pregnancy, liver disease)
Succinylmonochline is a weak active metabolite
Dosing:
1-1.5 mg/kg IV for rapid sequence, 2 mg/kg IV in smaller children, 3-5 mg/kg IM, 20 mg IV for laryngospasm
Onset: 30-60 sec IV, 2-5 min IM
Duration: < 10 min IV, 10-30 min IM
Drug errors? most common pic
Misc biggest category …Succinylcholine 17.1% , inhalational 13.2, opioids, local,
Malignant Hyperthermia
Succinylcholine, inhalational anesthetics - releases Ca++ - sarcoplasmic reticulum, Mutations in the RYR1 gene (ryanodine receptor)- increased ETCO2
Nondepolarizing Relaxants intro
Compete with/block Ach at the nicotinic receptor alpha subunits on motor endplate inhibiting depolarization
Uses: Muscle Relaxation for surgery, intubation
Aminosteroids
Primarily liver breakdown, kidney excretion, minimal histamine release, highly ionized at physiologic pH, small volume of distribution, limited lipid solubility
Potential for allergic reactions
Nondepolarizing Relaxants
Rocuronium (Zemuron)
Rocuronium (Zemuron) (50mg/100mg vials, 10mg/ml)
Intermediate action, rare histamine release, no effect of BP or HR, can be used to defasciculate with SUX
Dose:
0.6/1.2 mg/kg (higher dose for RSI and lower dose for routine intubation/surgical relaxation)
5 mg for defasciculating dose with SUX
Maintenance/Repeat dose of 0.1-0.2 mg/kg as needed
Pharmacodynamics
Onset: 1-2 min depending on dose
Duration: about 30 min
Eliminated primarily by the liver
Nondepolarizing Relaxants- Vecuronium
Vecuronium (Norcuron) (10mg 1mg/ml)
Intermediate NMB, no histamine release, cardiac stable, might precipitate with Thiopental
Dose:
Induction/intubation: 0.08-0.1 mg/kg
Pretreatment/priming with 10% of intubation dose Maintenance for surgical relaxation: 0.01 mg/kg
Pharmacodynamics
Onset: 2-3 min (good intubating conditions); 3-5 min (maximal blockade)
Nondepolarizing Relaxant- Pancuronium
Pancuronium (Pavulon) (10mg - 1mg/ml)
Long acting, no histamine release, modest tachycardia due to antimuscarinic stimulation, norepinephrine release and reduced uptake of norepinephrine by adrenergic nerves
Increase in BP, careful in any patient that will not tolerate increase HR and cardiac output
Dose:
Initial: .08-.12 mg/kg
Maintenance: 0.01 mg/kg
Pharmacodynamics
Onset: 2-3 min
Duration: 60-100 min
Benzylisoquinolines Intro
Hofmann Elimination
Ester hydrolysis
Plasma cholinesterase metabolism
Histamine release
Some changes to BP and HR
Hofmann Elimination
Spontaneous, non-enzymatic, non-organ dependent chemical breakdown at physiologic temperature and pH
Temperature increase and pH increases……. Increased metabolism
Temperature decreases and pH decreases……. Decreased metabolism
Benzylisoquinolines- Mivacurium (Mivacron)
10mg/20mg vial 2mg/ml -
HISTAMINE RELEASE when given quickly
Spontaneous recovery from the block is rapid
Metabolism:
Hydrolysis by plasma cholinesterase
Dose: .15-.2 mg/kg (intubation) 4-10 mcg/kg/min infusion
Pharmacodynamics:
Onset: 1 min
Duration: 10-20 minutes
Benzylisoquinolines- Atracurium (Tracrium)
50mg 10mg/ml
Intermediate acting, Hofmann Elimination and nonspecific ester hydrolysis, small histamine release, minimal change in BP
Primary metabolite is Laudanosine, which can produce rare seizure activity (tertiary amine)
Dose: 0.3-0.6 mg/kg
Pharmacodynamics
Onset: 2-3 minutes
Duration: 20-35 min, 95% recovery in 60-70 min
Benzylisoquinolines - Cisatrcurium (Nimbex)
20mg 2mg/ml
Intermediate/long acting, predominantly Hofmann elimination, NO histamine release, NO changes in BP/HR
Dose: 0.1-.15 mg/kg IV
Onset: 2-3 min, peaks in 3-5 min
Duration: 40-70 min; 20-35 min to begin recovery: up to 93 min for 90% return
Reactions- drugs that cause anaphylaxis reactions
Under anesthesia what would you see tachycardia, hypotension, bronchospasm – wheezy peak pressure – different than an awake pt. sugammadex (high doses) , rocuronium, antibiotics
Factors Affecting Reversal
Intensity of the block
Dose and choice of NMB
Drug interactions
Choice of reversal agent
Disease process (liver failure)
ways to reverse a patient?
Time, drugs, Hoffman
Acetylcholinesterase Inhibitors
Acetylcholinesterase : enzyme responsible for rapid hydrolysis of released acetylcholine
Reversal of NMB, myasthenia gravis (Diagnosis and treatment), treatment of central anticholinergic syndrome
Inhibiting the action of acetylcholinesterase, Increase Ach
Unwanted muscarinic stimulation
SLUD- salivation, lacrimation, urination, and defecation, which are the clinical signs associated with muscarinic cholinergic overstimulation(I ADDED)
Increased bronchial secretions/bronchospasm
Bradycardia caused by slowing conduction velocity of the cardiac impulse through the AV node
CNS excitement (physostigmine)
Reversal Agents - Acetylcholinesterase Inhibitors/Selective Relaxant Binding Agent
Acetylcholinesterase Inhibitors
Neostigmine
Edrophonium
Pyridostigmine
Selective Relaxant Binding Agent
Sugammadex
Acetylcholinesterase inhibitors - Neostigmine (Prostigmin)
10mg 1mg/ml
Inhibits hydrolysis of ACh by AChAsE
Blocks AChAse at all cholinergic synapses causing parasympathetic effects
Used with glycopyrrolate (anticholinergic) to decrease muscarinic side effects of Neostigmine
Quaternary ammonium compound therefore does not penetrate the blood-brain barrier (BBB) very well
Ceiling effect- 5mg
When to Reverse with Neostigmine..
Used in deep blocks
Shouldn’t be given until spontaneous recovery evident (TOF)
More effective with moderate blocks but slow acting
Ceiling effect
Because of this ceiling effect Neostigmine can’t effectively antagonize deep blocks
Giving more may even worsen it and potentially increase the incidence of residual block
15 mins when at right time? I ad ded
Given with Glycopyrrolate- .2mg/ml 5ml vial =1 mg
Acetylcholinesterase inhibitor Edrophoniun (Enlon)
Used with atropine due to rapid onset
Inhibits the destruction of ACh by AChE
Enlon-Plus is a mixture of Edrophonium and atropine together in the same vial
Rapid onset (1-2 min), short duration
Quaternary amine
Dose:
.5-1 mg/kg mixed with atropine 0.014 mg per 1 mg of edrophonium
Enlon-plus: .05-.1 mg/kg slowly over 1 minute
Enlon plus!! Is a mixture with atropine***
Atropine is .4mg/ml 20ml vial? per pic
Cholinergic Syndrome (Crisis)
Excessive stimulation of Ach receptors: either direct stimulation of receptor or inhibition of acetylcholinesterase
Overstimulation of nicotinic and muscarinic receptors
How: Too much Anticholinesterase, organophosphate poisoning/nerve gas, certain drugs
Symptoms: Muscarinic (SLUD), muscle cramping, weakness, decrease BP/HR, CNS (restless, anxiety, confused, seizures, coma)
Treatment: Atropine, benzos (versed/valium),Oximes (pralidoxime, obidoxime)
Acetylcholinesterase inhibitor - Physostigmine (Antilirium)
Tertiary amine: only anticholinesterase (acetylcholinesterase inhibitor, cholinesterase inhibitor) that crosses the blood brain barrier
Not used for reversal of muscle relaxants
Used to treat anticholinergic toxicity
S/S: flushing, dry skin and mucous membranes, mydriasis with loss of accommodation, altered mental status, fever and urinary retention
CNS: restless, shivers, agitation, disoriented
Types of anticholinergics (atropine, scopolamine, antihistamines, antipsychotics, cyclic antidepressants)
Selective relaxant binding agent - Bridion (Sugammadex)
Used for reversal of Zemuron/Vecuronium
Selective relaxant binding agent that encapsulates rocuronium or vecuronium preventing its action: can reverse profound neuromuscular blockade
What’s the dose of Sugammadex?
Dosing for Rocuronium and Vecuronium
2 mg/kg TOF of 2
4 mg/kg 1-2 post-tetanic counts (PTC) and no TOF twitches
Dosing for Rocuronium only
16 mg/kg to reverse RSI dose of Rocuronium of 1.2 mg/kg after 3 minutes
What are the Warnings and Precautions on Sugammadex?
Anaphylaxis and Hypersensitivity
Bradycardia
Risk of coagulopathy and bleeding
Increases in PTT and PT, especially in those who were treated with heparin or low molecular weight heparin for thromboprophylaxis
Interactions with other drugs (hormonal contraceptives and Toremifene)……… suggest NO sex for 7 days
Common adverse reactions: N/V, hypotension, headache
Anticholinergic Agents/Muscarinic Antagonists
- Muscarinic Antagonists
Competitive inhibitors of Ach at parasympathetic muscarinic receptors to increase the heart rate
Inhibits salivary, bronchial, and GI secretions
Reduces gastric motility
Causes bronchodilation
Antagonize the muscarinic effects of anticholinesterases used to reverse NDMR
Atropine
Competitive acetylcholine antagonist at central and peripheral receptors, antimuscarinic, naturally occurring alkaloid
Tertiary amine
Indications: reversal, brady arrhythmias/vagal stimulation, oculocardia reflex, peritoneal stimulation
Careful use in narrow-angle glaucoma
Crosses placenta to increase FHR and decrease beat to beat variability in baby
Dose: 0.014mg / mg of edrophonium or .2-.4mg for vagal stimulation
Onset: <1 min; duration: up to 30 min
Dilating an eye with narrow angle glaucoma closes the angle completely. Medications can worsen both types of glaucoma.
Glycopyrrolate (Robinul)
1mg .2mg/ml
Synthetic antimuscarinic, competitive Ach antagonist
Uses: in combo with Neostigmine for reversal, antisialogogue(xerostomia), increase HR
Quaternary ammonium
Dose: 0.2 mg per 1 mg Neostigmine
Onset: about 1 min IV; 15-30 min IM
Duration: 2-4 hours
No CNS or mydriasis
Scopolamine
.4mg/ml
Competitive antagonist of Ach at muscarinic receptors, antagonizes histamine and serotonin
Tertiary amine, naturally occurring alkaloid
Uses: Decreases secretions, PONV, motion sickness/vertigo, dilate pupils and cycloplegia, unstable trauma pt, sedation/amnesia
Toxic psychosis in elderly
Effects from restlessness to agitation
IM/IV before surgery; transdermal patch (what should we warn them about)
Typical dose: 0.3-.5 mg IM or IV
Cycloplegia: paralyzing the ciliary muscle and thus the power of accommodation.
Crosses BBB – more geared toward motion sickness- different drug with different modes of action for PONV – careful with older pts
dilate eyes… Also dry mouth***
Central Anticholinergic Syndrome
Overdose of scopolamine and sometimes Atropine(tertiary amines), phenothiazine
Signs: anxiety, disoriented, hyperactive, sedation, seizure, mydriasis, increased HR, Atropine flush, dry/flushed skin, atropine fever
Can be mistaken for delayed recovery from anesthesia
Treat with Physostigmine: tertiary amine that crosses the BBB
Dose: 1-2 mg IV and may need to be repeated every 1-2 hours (physostigmine is metabolized rapidly)
Muscarinic Antagonist Toxicity
Anticholineric toxidrome - pic
- *Vasopressors/**
- *Sympathomimetics- Vasopressors are not a replacement for:**
Adequate volume
Blood
TOO MUCH ANESTHESIA
Ephedrine
Mixed acting synthetic noncatecholamine sympathomimetic
Indirect Effect
Ephedrine into Alpha-1 and Beta-1 receptors displaces norepinephrine presynaptic
Norepi is released and activates the postsynaptic receptors to cause arterial and venous vasoconstriction and increased myocardial contraction
Direct Effect
Directly stimulates Beta-2
Increased heart rate, cardiac output and some SVR increase
Uses: increase BP/HR, CO and contractility, PONV, bronchodilator effect
Used in Obstetrics: can cause fetal tachycardia and acidosis which was associated with lower umbilical artery pH at delivery
Contraindicated with MAO inhibitors, Pheochromocytoma
Careful use in CAD
Tachyphylaxis (depletion of presynaptic norepi)
Dose: 5-10 mg at a time to increase BP/HR; Ephedrine 25mg/Vistaril 25 mg IM for antiemetic effect 20 min before end of surgery
50mg 5mg/ml - make by taking 1ml with 9ml of normal saline = 1cc (50 mg) + 9 cc of NS = 5 mg/cc
Phenylephrine (Neosynephrine)
Directly stimulates alpha-1 receptors, minimal effect on alpha-2 or Beta receptors
Uses: hypotension, decrease CO in patients with LV dysfunction
Causes constriction of cutaneous, mesenteric, splenic and renal
Vasopressor of choice in OB
Causes vasoconstriction to increase BP, reflex decrease in HR, increase in coronary blood flow
Dose: 50-100 mcg titration to effect
100 mcg/ml 1g in 10ml how to mix = .1 cc (10mg/cc vial) + 9.9 cc NS = 100 mcg/cc